Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: ABT-869|DRUG: paclitaxel|DRUG: Placebo for ABT-869
Sponsor: AbbVie (prior sponsor, Abbott)
Collaborators: Genentech, Inc.